Meet our speakers


The LSX Nordic Congress speaker faculty represents a selection of the best minds in Nordic life sciences and pan-European investment. 

 

Adam Kostyal, SVP, Nasdaq

Adam Kostyal

SVP
Nasdaq
Bobby Soni, CBO, BioInnovation Institute

Bobby Soni

CBO
BioInnovation Institute
Felicia Rittemar, Partner - Head of Life Science, Vator Securities

Felicia Rittemar

Partner - Head of Life Science
Vator Securities
Jonathan Gertler, Managing Director, BioVentures MedTech Funds and CEO, Back Bay Life Science Advisors

Jonathan Gertler

Managing Director
BioVentures MedTech Funds
John Drakenberg Renander, CEO, Alex Therapeutics

John Drakenberg Renander

CEO
Alex Therapeutics
Julia Fransson, CEO, MSC Nordics

Julia Fransson

CEO
MSC Nordics
Ingrid Teigland Akay, Managing Partner, Hadean Ventures

Ingrid Teigland Akay

Managing Partner
Hadean Ventures
Kim Baden-Kristensen, CEO, Brain+

Kim Baden-Kristensen

CEO
Brain+
Carsten Borring, Head of Listings & Capital Markets, Nasdaq Copenhagen

Carsten Borring

Head of Listings & Capital Markets
Nasdaq Copenhagen
Giovanni Rizzo, Venture Partner, Indaco Venture Partners

Giovanni Rizzo

Venture Partner
Indaco Venture Partners
Jacob Falck Hansen, Partner, Lundbeckfonden BioCapital

Jacob Falck Hansen

Partner
Lundbeckfonden BioCapital
Nina Haldipur, Senior Investment Manager, Vækstfonden

Nina Haldipur

Senior Investment Manager
Vækstfonden
Pekka Simula, Partner, Innovestor Life Science

Pekka Simula

Partner
Innovestor Life Science
Hiroyuki Usuda, Senior Manager S&E Business Development, Astellas Europe

Hiroyuki Usuda

Senior Manager S&E Business Development
Astellas Europe
Anette Steenberg, CEO, Medicon Valley Alliance-1

Anette Steenberg

CEO
Medicon Valley Alliance
Farzad Abdi-Dezfuli, Partner, Life Science Investments, Sarsia

Farzad Abdi-Dezfuli

Partner, Life Science Investments
Sarsia
Anta Gkelou, Principal, Capital Strategy, Sofinnova Partners

Anta Gkelou

Principal, Capital Strategy
Sofinnova Partners
Thomas Holm Pedersen, CEO, NMD Pharma

Thomas Holm Pedersen

CEO
NMD Pharma
Stephan Christgau, Managing Partner, Eir Ventures 300x-1

Stephan Christgau

Managing Partner
Eir Ventures
Thomas Black-Petersen,Director, FBV

Thomas Black-Petersen

Director
FBV
Thomas Tan, Principal, Sound Bioventures

Thomas Tan

Principal
Sound Bioventures
Rita Balice Gordon, CEO, Muna Therapeutics

Rita Balice Gordon

CEO
Muna Therapeutics
Max Klement, Principal, Novo Ventures

Max Klement

Principal
Novo Ventures
Mads Lacoppidan, Investment Director, Vækstfonden

Mads Lacoppidan

Investment Director
Vækstfonden
Jonas Hjortshøj, CCO, Liva Healthcare

Jonas Hjortshøj

CCO
Liva Healthcare
Jan Alan Alfheim, CEO, Oncoinvent

Jan Alan Alfheim

CEO
Oncoinvent
MartenSteen-HealthCap

Mårten Steen

Managing Partner
HealthCap
Christian Elling, Managing Partner Lundbeckfonden BioCapital

Christian Elling

Managing Partner
Lundbeckfonden BioCapital
Frank Jaskulke, VP Intelligence, Head of Medical Alley Starts, Medical Alley

Frank Jaskulke

VP Intelligence, Head of Medical Alley Starts
Medical Alley
Cristiana Pires, CEO Asgard-1

Cristiana Pires

CEO
Asgard
Don DeBethizy, Director, Argenx

Don DeBethizy

Director
Argenx
Nanna Soni, Director, Coulter Partners

Nanna Soni

Director
Coulter Partners
Hans Schambye, President & CEO, Galecto

Hans Schambye

President & CEO
Galecto
DOWNLOAD BROCHURE